Summary by Futu AI
Michael R. McMullen, associated with Bristol-Myers Squibb (BMY), was involved in a transaction with the company's stock on July 29, 2024. Specific details regarding the nature of the transaction, such as the action type, number of shares, transaction price, and the resulting ownership stake, were not disclosed in the announcement.